Search: onr:"swepub:oai:gup.ub.gu.se/96640" >
Tidig immunterapi v...
Tidig immunterapi vid MS minskar risk för senare handikapp. Sekundärprogressivt förlopp fördröjs, enligt studie med virtuell placebo : [Early immunotherapy in MS reduces the risk of later disability. The secondary progressive course is delayed, according to a study with virtual placebo]
-
- Tedeholm, Helen, 1978 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap och rehabilitering,Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation
-
Skoogh, B (author)
-
Hillert, Jan (author)
-
show more...
-
Runmarker, Björn (author)
-
Stawiarz, Leszek (author)
-
- Andersen, Oluf, 1941 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap och rehabilitering,Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation
-
show less...
-
(creator_code:org_t)
- 2007
- 2007
- Swedish.
-
In: Läkartidningen. - 0023-7205. ; 104:22, s. 1684-8
- Related links:
-
https://gup.ub.gu.se...
Subject headings
Close
Keyword
- Adjuvants
- Immunologic
- therapeutic use
- Adult
- Cohort Studies
- Disability Evaluation
- Disease Progression
- Female
- Humans
- Immunoglobulins
- Intravenous
- therapeutic use
- Immunologic Factors
- therapeutic use
- Interferon-beta
- therapeutic use
- Male
- Middle Aged
- Multiple Sclerosis
- complications
- drug therapy
- immunology
- Peptides
- therapeutic use
- Placebos
- Prognosis
- Registries
- Treatment Outcome
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database